Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Nevens, Frederik" or (type any "bookEditor issueEditor" and editor="Nevens, Frederik")

Add to list
COVID-19 in an international European liver transplant recipient cohort

Chiara Becchetti, Marco Fabrizio Zambelli, Luisa Pasulo, Maria Francesca Donato, Federica Invernizzi, Olivier Detry, Geraldine Dahlqvist, Olga Ciccarelli, Maria Cristina Morelli, Montserrat Fraga, et al.

(2020) GUT. 69(10). p.1832-1840
Add to list
Factors associated with progression and outcomes of early stage primary biliary cholangitis

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry LA Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2020) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 18(3). p.684-692
Add to list
- Journal Article
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Nikolaos K. Gatselis, Jorn C. Goet, Kalliopi Zachou, Willem J. Lammers, Harry L. A. Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D. Lindor, Pietro Invernizzi, Marlyn J. Mayo, et al.

(2020) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 18(3). p.684-+
Add to list
- Journal Article
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Carla F. Murillo Perez, Maren H. Harms, Keith D. Lindor, Henk R. van Buuren, Gideon M. Hirschfield, Christophe Corpechot, Adriaan J. van der Meer, Jordan J. Feld, Aliya Gulamhusein, Willem J. Lammers, et al.

(2020) AMERICAN JOURNAL OF GASTROENTEROLOGY. 115(7). p.1066-1074
Add to list
- Journal Article
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis

Christophe Corpechot, Olivier Chazouilleres, Pierre Belnou, Aldo J. Montano-Loza, Andrew Mason, Maryam Ebadi, Dennis Eurich, Sascha Chopra, Dietmar Jacob, Christoph Schramm, et al.

(2020) JOURNAL OF HEPATOLOGY. 73(3). p.559-565
Add to list
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion

Stijn Van Hees, Heng Chi, Bettina Hansen, Stefan Bourgeois, Hans Van Vlierberghe (UGent) , Thomas Serste, Sven Francque, David Wong, Dirk Sprengers, Christophe Moreno, et al.

(2019) JOURNAL OF VIRAL HEPATITIS. 26(6). p.766-769
Add to list
Outcome of liver transplantation for hepatopulmonary syndrome : a Eurotransplant experience

Sarah Raevens, Xavier Rogiers (UGent) , Anja Geerts (UGent) , Xavier Verhelst (UGent) , Undine Samuel, Marieke van Rosmalen, Gabriela Berlakovich, Jean Delwaide, Olivier Detry, Frank Lehner, et al.

(2019) EUROPEAN RESPIRATORY JOURNAL. 53(2).
Add to list
- Conference Paper
- C3
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Rozanne de Veer, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.783A-785A
Add to list
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Carla F. Murillo Perez, Gideon M. Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J. Mayo, Adriaan van der Meer, Cyriel Y. Ponsioen, Willem J. Lammers, Albert Pares, Pietro Invernizzi, et al.

(2019) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 50(10). p.1127-1136
Add to list
- Conference Paper
- C3
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Rozanne de Veer, Maren H Harms, Jorn Goet, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.776A-777A

Academic Bibliography

COVID-19 in an international European liver transplant recipient cohort

Factors associated with progression and outcomes of early stage primary biliary cholangitis

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis

Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion

Outcome of liver transplantation for hepatopulmonary syndrome : a Eurotransplant experience

Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Contents

Support

Contact